NIFTY 50
22,904.45 (-1.49%)
NIFTY IT
33,511.40 (-3.58%)
NIFTY AUTO
20,593.15 (-2.70%)
NIFTY FINANCIAL SERVICES
24,774.30 (0.20%)
NIFTY BANK
51,502.70 (-0.18%)
NIFTY REALTY
823.05 (-3.60%)
NIFTY ENERGY
32,308.90 (-3.73%)
NIFTY METAL
8,414.45 (-6.56%)
NIFTY FMCG
53,830.70 (0.04%)
NIFTY HEALTH CARE
13,426.80 (-3.05%)
NIFTY PHARMA
20,560.00 (-4.03%)
NIFTY MEDIA
20,560.00 (-4.03%)
Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

    Profit & Loss
Change Company Name
Dr Reddys Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 500124 ISIN Demat INE089A01031 Book Value 322.46 NSE Symbol DRREDDY Dividend Yield (%) 0.69 Market Cap ( Cr.) 96,066.67 P/E 18.53 EPS 62.12 Face Value 1
Particulars (₹ Cr)Mar2024Mar2023Mar2022Mar2021Mar2020
Revenue From Operations 19,483.8016,962.5014,405.2013,349.1011,850.40
Sale of Products19,325.3016,338.0013,921.2013,236.4011,023.10
Sale of Services127.70600.20428.9072.00810.50
Income from Investment and Financial Services0.000.000.000.000.00
Income from Insurance Operations0.000.000.000.000.00
Other Operating Revenue30.8024.3055.1040.7016.80
Less: Excise Duty / GST0.000.000.000.000.00
Revenue From Operations - Net19,483.8016,962.5014,405.2013,349.1011,850.40
Other Income862.30591.30482.00801.10743.20
Total Revenue20,346.1017,553.8014,887.2014,150.2012,593.60
Changes in Inventories-238.80129.50-389.60-395.60-99.90
Cost of Material Consumed3,291.503,161.403,378.403,266.302,556.50
Internally Manufactured Intermediates Consumed0.000.000.000.000.00
Purchases of Stock-in-Trade1,986.601,779.302,057.101,252.301,117.20
Employee Benefits3,085.702,832.602,434.602,270.102,030.20
Total Other Expenses 5,432.404,844.904,330.603,819.203,376.80
Manufacturing / Operating Expenses2,010.401,656.001,365.701,244.301,104.90
Administrative and Selling Expenses3,064.602,782.802,672.902,274.902,026.80
Other Expenses357.40406.10292.00300.00245.10
Finance Costs21.8016.9038.0046.7047.80
Depreciation and Amortization975.60923.20814.30835.00789.20
Total Expenses14,554.8013,687.8012,663.4011,094.009,817.80
Profit Before Exceptional Items and Tax5,791.303,866.002,223.803,056.202,775.80
Exceptional Items Before Tax0.000.000.000.000.00
Profit Before Extraordinary Items and Tax5,791.303,866.002,223.803,056.202,775.80
Extraordinary Items Before Tax0.000.000.000.000.00
Other Adjustments Before Tax0.000.000.000.000.00
Profit Before Tax5,791.303,866.002,223.803,056.202,775.80
Taxation1,449.301,253.20600.60869.80-161.90
Current Tax1,361.80864.10392.60540.10483.90
MAT Credit Entitlement0.000.000.000.000.00
Deferred Tax87.50389.10208.00329.70-645.80
Other Tax0.000.000.000.000.00
Adjust for Previous Year0.000.000.000.000.00
Profit After Tax4,342.002,612.801,623.202,186.402,937.70
Extraordinary Items After Tax0.000.000.000.000.00
Discontinued Operations After Tax0.000.000.000.000.00
Profit / (Loss) from Discontinuing Operations0.000.000.000.000.00
Tax Expenses of Discontinuing Operations0.000.000.000.000.00
Profit Attributable to Shareholders4,342.002,612.801,623.202,186.402,937.70
Adjustments to Net Income0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Profit Attributable to Equity Shareholders4,342.002,612.801,623.202,186.402,937.70
Earning Per Share - Basic260.95157.3797.85131.84177.23
Earning Per Share - Diluted260.46157.0397.58131.46176.88
Operation Profit before Depreciation6,788.704,806.103,076.103,937.903,612.80
Operating Profit after Depreciation5,813.103,882.902,261.803,102.902,823.60
Dividend Per Share40.0040.0030.0025.0025.00
Dividend Percentage800.00800.00600.00500.00500.00
Equity Dividend667.30666.11499.28415.75415.43
Weighted Average Shares - Basic16.6416.6016.5916.5816.58
Weighted Average Shares - Diluted16.6716.6416.6316.6316.61
  • Copyright © 2024   INVES 21
  • Designed, developed and Content Provide by CMOTS Infotech (ISO 9001:2015 certified)